Selected research
Industry Research
Primary Antibody Industry Research Report 2026
Market perspective
The global Primary Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Primary Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Primary Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Primary Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Primary Antibody include Thermo Fisher Scientific, Roche Diagnostics, SouthernBiotech, Proteintech, OriGene, Novus Biologicals, HyTest, Genscript Biotech and Creative Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Primary Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/mg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Primary Antibody Market by Company
Thermo Fisher Scientific
Roche Diagnostics
SouthernBiotech
Proteintech
OriGene
Novus Biologicals
HyTest
Genscript Biotech
Creative Diagnostics
Boster Bio
Biorbyt
Bio-Rad
Abcam
Primary Antibody Segment by Type
Monoclonal Antibodies
Polyclonal Antibody
Primary Antibody Segment by Application
Life Sciences
Laboratory
Hospital
Primary Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primary Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primary Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primary Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Primary Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Primary Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Primary Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibodies
- Polyclonal Antibody
Applications
- Life Sciences
- Laboratory
- Hospital
Companies covered
- Thermo Fisher Scientific
- Roche Diagnostics
- SouthernBiotech
- Proteintech
- OriGene
- Novus Biologicals
- HyTest
- Genscript Biotech
- Creative Diagnostics
- Boster Bio
- Biorbyt
- Bio-Rad
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Primary Antibody Market Size (2021-2032)
- 2.2.2 Global Primary Antibody Sales (2021-2032)
- 2.2.3 Global Primary Antibody Market Average Price (2021-2032)
- 2.3 Primary Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Monoclonal Antibodies
- 2.3.3 Polyclonal Antibody
- 2.4 Primary Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Life Sciences
- 2.4.3 Laboratory
- 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Primary Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Primary Antibody Sales (mg) of Manufacturers (2021-2026)
- 3.3 Global Primary Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global Primary Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global Primary Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Primary Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Primary Antibody, Product Type & Application
- 3.8 Global Manufacturers of Primary Antibody, Established Date
- 3.9 Global Primary Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Primary Antibody Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Roche Diagnostics
- 4.2.1 Roche Diagnostics Company Information
- 4.2.2 Roche Diagnostics Business Overview
- 4.2.3 Roche Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Diagnostics Primary Antibody Product Portfolio
- 4.2.5 Roche Diagnostics Recent Developments
- 4.3 SouthernBiotech
- 4.3.1 SouthernBiotech Company Information
- 4.3.2 SouthernBiotech Business Overview
- 4.3.3 SouthernBiotech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SouthernBiotech Primary Antibody Product Portfolio
- 4.3.5 SouthernBiotech Recent Developments
- 4.4 Proteintech
- 4.4.1 Proteintech Company Information
- 4.4.2 Proteintech Business Overview
- 4.4.3 Proteintech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Proteintech Primary Antibody Product Portfolio
- 4.4.5 Proteintech Recent Developments
- 4.5 OriGene
- 4.5.1 OriGene Company Information
- 4.5.2 OriGene Business Overview
- 4.5.3 OriGene Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 OriGene Primary Antibody Product Portfolio
- 4.5.5 OriGene Recent Developments
- 4.6 Novus Biologicals
- 4.6.1 Novus Biologicals Company Information
- 4.6.2 Novus Biologicals Business Overview
- 4.6.3 Novus Biologicals Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novus Biologicals Primary Antibody Product Portfolio
- 4.6.5 Novus Biologicals Recent Developments
- 4.7 HyTest
- 4.7.1 HyTest Company Information
- 4.7.2 HyTest Business Overview
- 4.7.3 HyTest Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HyTest Primary Antibody Product Portfolio
- 4.7.5 HyTest Recent Developments
- 4.8 Genscript Biotech
- 4.8.1 Genscript Biotech Company Information
- 4.8.2 Genscript Biotech Business Overview
- 4.8.3 Genscript Biotech Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Genscript Biotech Primary Antibody Product Portfolio
- 4.8.5 Genscript Biotech Recent Developments
- 4.9 Creative Diagnostics
- 4.9.1 Creative Diagnostics Company Information
- 4.9.2 Creative Diagnostics Business Overview
- 4.9.3 Creative Diagnostics Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Creative Diagnostics Primary Antibody Product Portfolio
- 4.9.5 Creative Diagnostics Recent Developments
- 4.10 Boster Bio
- 4.10.1 Boster Bio Company Information
- 4.10.2 Boster Bio Business Overview
- 4.10.3 Boster Bio Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boster Bio Primary Antibody Product Portfolio
- 4.10.5 Boster Bio Recent Developments
- 4.11 Biorbyt
- 4.11.1 Biorbyt Company Information
- 4.11.2 Biorbyt Business Overview
- 4.11.3 Biorbyt Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Biorbyt Primary Antibody Product Portfolio
- 4.11.5 Biorbyt Recent Developments
- 4.12 Bio-Rad
- 4.12.1 Bio-Rad Company Information
- 4.12.2 Bio-Rad Business Overview
- 4.12.3 Bio-Rad Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bio-Rad Primary Antibody Product Portfolio
- 4.12.5 Bio-Rad Recent Developments
- 4.13 Abcam
- 4.13.1 Abcam Company Information
- 4.13.2 Abcam Business Overview
- 4.13.3 Abcam Primary Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abcam Primary Antibody Product Portfolio
- 4.13.5 Abcam Recent Developments
5 Global Primary Antibody Market Scenario by Region
- 5.1 Global Primary Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Primary Antibody Sales by Region: 2021-2032
- 5.2.1 Global Primary Antibody Sales by Region: 2021-2026
- 5.2.2 Global Primary Antibody Sales by Region: 2027-2032
- 5.3 Global Primary Antibody Revenue by Region: 2021-2032
- 5.3.1 Global Primary Antibody Revenue by Region: 2021-2026
- 5.3.2 Global Primary Antibody Revenue by Region: 2027-2032
- 5.4 North America Primary Antibody Market Facts & Figures by Country
- 5.4.1 North America Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Primary Antibody Sales by Country (2021-2032)
- 5.4.3 North America Primary Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Primary Antibody Market Facts & Figures by Country
- 5.5.1 Europe Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Primary Antibody Sales by Country (2021-2032)
- 5.5.3 Europe Primary Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Primary Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Primary Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Primary Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Primary Antibody Market Facts & Figures by Country
- 5.7.1 South America Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Primary Antibody Sales by Country (2021-2032)
- 5.7.3 South America Primary Antibody Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Primary Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Primary Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Primary Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Primary Antibody Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Primary Antibody Sales by Type (2021-2032)
- 6.1.1 Global Primary Antibody Sales by Type (2021-2032) & (mg)
- 6.1.2 Global Primary Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global Primary Antibody Revenue by Type (2021-2032)
- 6.2.1 Global Primary Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Primary Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global Primary Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Primary Antibody Sales by Application (2021-2032)
- 7.1.1 Global Primary Antibody Sales by Application (2021-2032) & (mg)
- 7.1.2 Global Primary Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global Primary Antibody Revenue by Application (2021-2032)
- 7.2.1 Global Primary Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Primary Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global Primary Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Primary Antibody Value Chain Analysis
- 8.1.1 Primary Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Primary Antibody Production Mode & Process
- 8.2 Primary Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Primary Antibody Distributors
- 8.2.3 Primary Antibody Customers
9 Global Primary Antibody Analyzing Market Dynamics
- 9.1 Primary Antibody Industry Trends
- 9.2 Primary Antibody Industry Drivers
- 9.3 Primary Antibody Industry Opportunities and Challenges
- 9.4 Primary Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst